Lv2
194 积分 2025-11-10 加入
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis
6天前
已完结
Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors
6天前
已完结
How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches
8天前
已完结
Bromodomain containing protein 4 (BRD4) and cancer therapy: A glimpse at dual-target drug development
8天前
已完结
Compromised epigenetic robustness in cancer: fueling evolution, exposing weakness
8天前
已完结
GSPT1 degraders: research progress, development strategies and challenges
8天前
已完结
Brusatol ameliorates irinotecan-induced delayed diarrhea via inhibition of the cGAS-STING pathway and modulation of intestinal flora
9天前
已完结
Irinotecan: 25 years of cancer treatment
9天前
已完结
Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway
10天前
已完结
Emerging roles of E2Fs in cancer: an exit from cell cycle control
10天前
已完结
皖公网安备34019202002308
